← back to search

Michiel C.T. van Zeijl

Dutch Institute for Clinical Auditing · NL
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, and Melanoma and MAPK Pathways.
h-index
15
citations
848
works
23
NIH funding
primary concept
Medicine
email

Recent publications

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
Cancers 2019cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John B.A.G. Haanen · Nikki-Universal (Japan)1 papers (2019–2019)Albert J. ten Tije · Amphia Ziekenhuis1 papers (2019–2019)Jan Willem B. de Groot · Isala1 papers (2019–2019)Djura Piersma · Medisch Spectrum Twente1 papers (2019–2019)Ellen Kapiteijn · University of Amsterdam1 papers (2019–2019)Gerard Vreugdenhil · Association of British Orchestras1 papers (2019–2019) · 1 papers (2019–2019)Michel W.J.M. Wouters · Northwestern University1 papers (2019–2019)Rozemarijn S. van Rijn · Medisch Centrum Leeuwarden1 papers (2019–2019)Alfons J.M. van den Eertwegh · Amsterdam Neuroscience1 papers (2019–2019)Alexander C. J. van Akkooi · The University of Sydney1 papers (2019–2019) · 1 papers (2019–2019)Karijn P.M. Suijkerbuijk · Utrecht University1 papers (2019–2019)Franchette W.P.J. van den Berkmortel · Zuyderland Medisch Centrum1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019)Rutger H.T. Koornstra · Radboud University Medical Center1 papers (2019–2019)Geke A.P. Hospers · University Medical Center Groningen1 papers (2019–2019)